Text Size
52 studies found for:    Paraneoplastic Syndromes

Modify this search | How to Use Search Results

Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Cancel
Rank Status Study
1 Recruiting Immunotherapy of the Paraneoplastic Syndromes
Condition: Paraneoplastic Syndromes
Intervention: Drug: Tacrolimus (FK506)
2 Completed Studies of Neurological Paraneoplastic Syndromes
Condition: Paraneoplastic Neurologic Degenerations (PNDs)
Intervention:
3 Recruiting The Study of Immune Cell (T Cell) Activity in Patients With Paraneoplastic Neurologic Syndromes
Condition: Paraneoplastic Syndromes
Intervention:
4 Recruiting Observing the Changes of Fibroblast Growth Factor 23 in Patients of Tumor Induced Osteomalasia
Condition: Hypophosphatemia
Intervention:
5 Recruiting Study of Cytokines in Children With Opsoclonus-Myoclonus Syndrome
Condition: Opsoclonus-myoclonus Syndrome
Intervention:
6 Active, not recruiting MC-5A for Chemotherapy Induced Peripheral Neuropathy
Condition: Neuropathy, Paraneoplastic
Interventions: Device: MC-5A;   Drug: Sham device
7 Recruiting 3,4-Diaminopyridine Use in Lambert-Eaton Myasthenic Syndrome(LEMS) and Congenital Myasthenic Syndromes (CMS)
Conditions: Lambert-Eaton Myasthenic Syndrome;   Congenital Myasthenic Syndrome
Interventions: Drug: 3,4-DIAMINOPYRIDINE;   Drug: 3,4-Diaminopyridine
8 Recruiting Efficacy of Albuterol in the Treatment of Congenital Myasthenic Syndromes
Condition: Congenital Myasthenic Syndrome
Intervention: Drug: Albuterol
9 Available Treatment of Lambert-Eaton Syndrome With 3,4 DAP
Condition: Lambert Eaton Myasthenic Syndrome
Intervention: Drug: 3, 4 DAP
10 Available Treatment of Lambert-Eaton Myasthenic Syndrome (LEMS) With 3, 4 DAP
Condition: Lambert Eaton Myasthenic Syndrome (LEMS)
Intervention: Drug: 3,4-diaminopyridine
11 Recruiting Effectiveness of 3,4-Diaminopyridine in Lambert-Eaton Myasthenic Syndrome
Conditions: Lambert-Eaton Myasthenic Syndrome;   Eaton-Lambert Myasthenic Syndrome
Interventions: Drug: 3,4-DAP;   Drug: 3,4-DAP Taper to Placebo
12 Recruiting Use of 3,4-Diaminopyridine in the Treatment of Lambert-Eaton Syndrome
Condition: Lambert Eaton Myasthenic Syndrome
Intervention: Drug: 3, 4-Diaminopyridine
13 Unknown † Treatment of Lambert-Eaton Syndrome With 3,4 Diaminopyridine
Condition: Lambert-Eaton Myasthenic Syndrome
Intervention: Drug: 3,4 diaminopyridine
14 Available Compassionate Use of 3,4-Diaminopyridine
Conditions: Lambert Eaton Myasthenic Syndrome (LEMS);   Myasthenic Syndromes, Congenital
Intervention: Drug: 3,4-diaminopyridine
15 Available Use Of 3,4-Diaminopyridine (3,4-DAP) In The Treatment Of Lambert Eaton Myasthenic Syndrome
Condition: Lambert-Eaton Myasthenic Syndrome
Intervention: Drug: 3,4 DAP
16 Completed Pregnancy Outcomes in Congenital Myasthenie Syndrome
Condition: Congenital Myasthenic Syndrome
Intervention:
17 Recruiting A Phase 3 Study of Amifampridine Phosphate in Patients With Lambert Eaton Myasthenic Syndrome (LEMS)
Condition: Lambert Eaton Myasthenic Syndrome
Interventions: Drug: Amifampridine Phosphate;   Drug: Placebo
18 Completed Randomized Study of 3,4-Diaminopyridine for Lambert-Eaton Myasthenic Syndrome
Condition: Lambert-Eaton Myasthenic Syndrome
Intervention: Drug: 3,4-diaminopyridine
19 Completed Effectiveness of Rituximab in Pediatric OMS Patients.
Conditions: Opsoclonus-myoclonus Syndrome;   Opsoclonus;   Myoclonus;   Ataxia
Intervention: Drug: rituximab
20 Unknown † Cyclophosphamide and Prednisone With or Without Immunoglobulin in Treating Abnormal Muscle Movement in Children With Neuroblastoma
Condition: Neuroblastoma
Interventions: Biological: therapeutic immune globulin;   Other: clinical observation
To Top

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
† Indicates status has not been verified in more than two years